Effect of silymarin on streptozotocin-nicotinamide-induced type 2 diabetic nephropathy in rats

Iranian Journal of Kidney Diseases

Volumn 7, Issue 2, 2013, Pages 117-123

  Sheela, Nagarajan ^a   Jose, Manonmani Alvin ^a   Sathyamurthy, Duraiswami ^a   Kumar, Balasubramanian Nandha ^a  

^a SWAMY VIVEKANANDHA COLLEGE OF PHARMACY   (India)

Author keywords

Animal models; Diabetic nephropathies; Insulin resistance; Serum creatinine

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; NICOTINAMIDE; SILYMARIN; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY MASS; LOW DRUG DOSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; RENAL PROTECTION; STREPTOZOCIN DIABETES; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL; URINE VOLUME;

ALBUMINURIA; ANIMALS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HEMOGLOBIN A, GLYCOSYLATED; MALE; NIACINAMIDE; PROTECTIVE AGENTS; RATS; RATS, WISTAR; SILYMARIN; STREPTOZOCIN; URIC ACID;

EID: 84875135574     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Daisy P, Balasubramanian K, Rajalakshmi M, Eliza J, Selvaraj J. Insulin mimetic impact of Catechin isolated from Cassia fistula on the glucose oxidation and molecular mechanisms of glucose uptake on Streptozotocin-induced diabetic Wistar rats. Phytomedicine. 2010;17:28-26.
2. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 2005;52:313-320.
3. Kim OS, Kim YS, Jang DS, Yoo NH, Kim JS. Cytoprotection against hydrogen peroxide-induced cell death in cultured mouse mesangial cells by erigeroflavanone a novel compound from the flower of Erigeron annuus. Chem Biol Interact. 2009;180:414-420.
4. Chen KH, Hung CC, Hsu HH, Jing YH, Yang CW, Chen JK. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats. Chem Biol Interact. 2011;190:45-53.
5. Aryal M, Jha B. Assessment of proteinuria as a marker of nephropathy in type 2 diabetes mellitus. Nepal Med Coll J. 2006;8:250-253.
6. Annemans L, Demarteau N, Hu S, et al. An Asian regional analysis of cost-effectiveness of early irbesartan treatment versus conventional antihypertensive late amlodipine and late irbesartan treatment in patients with type 2 diabetes hypertension and nephropathy. Value Health. 2008;11:354-364.
7. Tang SC. Diabetic nephropathy: A global and growing threat. Hong Kong Med J. 2010;16:244-245.
8. Baig RM, Gillani WS, Sulaiman SA, Krishna RD, Narayanan K. Epidemiology of diabetic nephropathy in the poor patients from rural south-east India. Int J Food Saf Nutr Publ Health. 2011;4:55-61.
9. Soto C, Perez J, Garcia V, Uria E, Vadillo M, Raya L. Effect of silymarin on kidney of rats suffering from alloxan- induced diabetic mellitus. Phyton. 2010;17:1090-1094.
10. Jose MA, Abraham A, Narmada MP. Effect of silymarin in diabetes mellitus patients with liver diseases. J Pharmacol Pharmacother. 2011;2:287-289.
11. Huseini HF, Larijani B, Heshmat R, et al. The efficiency of silymarin in the treatment of type II diabetes: A randomized double- blind Placebo- controlled clinical trial. Phytother Res. 2006;20:1036-1039.
12. Velussi M, Cernigoi AM, De Monte A, Dapas F, Caffau C, Zilli M. Long-term (12 months) treatment with an antioxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. J Hepatol. 1997;26:871-879.
13. Jacobs PB, Dennehy C, Ramirez G, Sapp J, Lawrence VA. Milk thistle for the treatment of liver disease: A systematic review and meta-analysis. Am J Med. 2002;113:506-515.
14. Kumar EK, Janardhanan DK. Antidiabetic activity of alcoholic stem extract of Nervilia plicata in streptozotocin-nicotinamide induced type 2 diabetic rats. J Ethnopharmacol. 2011;133:480-483.
15. Skottova N, Krecman V. Silymarin as a potential hypocholesterolaemic drug. Physiol Res. 1998;47:11-17.
16. Karimi G, Vahabzadeh M, Lari P, Rashedinia M, Moshiri M. Silymarin a promising pharmacological agent for treatment of disease. Iran J Basic Med Sci. 2011;14:308-317.
17. Swanston-Fiatt SK, Day C, Bailey CJ, Flatt PR. Traditional plant treatments for diabetes: studies in normal and streptozotocin diabetic mice. Diabetologia. 1990;33:462-464.
18. Shirwaikar A, Rajendran K, Dinesh kumar C, Bodla R. Anti-diabetic activity of aqueous leaf extract of Annona squamosa in streptozotocin- nicotinamide type 2 diabetic rats. J Ethnopharmacol. 2004;91:171-175.
19. Kiran G, Nandini CD, Ramesh HP, Salimath PV. Progression of early phase diabetic nephropathy in streptozotocin-induced diabetic rats evaluation of various kidney related parameters. Indian J Exp Biol. 2012;50:133-140.
20. Grover JK, Vats V, Rathi SS, Dawar R. Traditional indian anti-diabetic plants attenuate progression of renal damage in streptozotocin induced diabetic mice. J Ethanopharmacol. 2001;76:233-238.
21. Ramkumar KM, Ponmanickam P, Velayuthaprabhu S, Archunan G, Rajaguru P. Protective effect of Gymnema montanum against renal damage in experimental diabetic rats. Food Chem Toxicol. 2009;47:2516-2525.
22. Jadhav GB, Upasani CD. Effect of Silymarin on DOCA salt streptozotocin induced diabetic hypertension in unilateral nephrectomized rats. Int J Pharm Res. 2011;1:27-32.
23. Abenavoli L, Gabriella A, Raffaele C, Natasa M, Francesco C. Milk thistle for treatment of non alcoholic fatty liver disease. Hepat Mon. 2011;11:173-177.
24. Chen B, Bestetti G, Day RM, Turner AP. The synthesis and screening of a combinatorial peptide library for affinity ligands for glycosylated haemoglobin. Biosens Bioelectron. 1998;13:779-785.
25. Noriega CR, Avila O, Gutierrez E, et al. Hypolipidemic activity of Eryngium carlinae on streptozotocin induced diabetic rats. Biochem Res Int. 2012;10:60-65.
26. Patel S, Shan SR, Goyal KR. Antihyperglycemic antihyperlipidemic and antioxidant effects a dihar a polyherbal ayurvedic formulation in streptozotocin induced diabetic rats. Indian J Exp Biol. 2009;47:564-570.
27. Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis. 2006;47:51-59.